financetom
Business
financetom
/
Business
/
Denali Capital, Longevity Biomedical Terminate Business Combination; Shares Jump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Denali Capital, Longevity Biomedical Terminate Business Combination; Shares Jump
Jun 27, 2024 10:18 AM

12:56 PM EDT, 06/27/2024 (MT Newswires) -- Denali Capital Acquisition ( DECA ) said Thursday that it and Longevity Biomedical have mutually agreed to terminate their proposed business combination deal.

Denali said it will seek "alternative ways to consummate an initial business combination."

Shares of the blank-check company surged more than 46% in recent trading.

Price: 11.35, Change: +3.58, Percent Change: +46.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Receives Conditional Approval for Tazverik as Follicular Lymphoma Treatment in China
Hutchmed Receives Conditional Approval for Tazverik as Follicular Lymphoma Treatment in China
Mar 21, 2025
07:28 AM EDT, 03/21/2025 (MT Newswires) -- Hutchmed (China) ( HCM ) said Friday that China's National Medical Products Administration granted conditional approval for the new drug application for Tazverik as a treatment for adult patients with relapsed or refractory follicular lymphoma. The company said results of a phase 2 trial supported the conditional approval, with Tazverik demonstrating promising efficacy....
Young, rich Indians rev up Lamborghini and Mercedes-Maybach sales
Young, rich Indians rev up Lamborghini and Mercedes-Maybach sales
Mar 21, 2025
By Aditi Shah NEW DELHI (Reuters) - Lamborghini and Mercedes-Maybach plan to expand in India as a growing tribe of young, rich Indians splurge on super luxury cars, driving their sales to record levels. Italian supercar maker Lamborghini, fresh from a year of record sales, is exploring a fourth showroom in India, while Mercedes-Maybach sees the country as a potential...
Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive
Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive
Mar 21, 2025
07:34 AM EDT, 03/21/2025 (MT Newswires) -- AstraZeneca ( AZN ) will invest $2.5 billion in a new research center in Beijing just months after the company's top executive was detained by Chinese authorities, Bloomberg reported Friday. AstraZeneca ( AZN ) did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations...
NIO Q4 Earnings: Revenue & EPS Miss, 45% Delivery Growth, Margin Gains And More
NIO Q4 Earnings: Revenue & EPS Miss, 45% Delivery Growth, Margin Gains And More
Mar 21, 2025
Chinese electric vehicle maker NIO, Inc ( NIO ) shares are trading lower premarket on Friday after the company reported fiscal fourth-quarter revenue of 19.70 billion Chinese yuan ($2.70 billion), up 15.2% year-over-year and up 5.5% sequentially. Analysts, on average, estimated revenue of $2.85 billion for the quarter. Excluding items, the company reported an adjusted loss per share per ADS of 3.17 Chinese yuan or 43 cent loss compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved